E-LIB Suche - Ergebnisse für: Reid, Joel M

1

A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhib..:

Janku, Filip ; Choong, Grace M. ; Opyrchal, Mateusz...
Cancers. 16 (2024) 6 - p. 1137 , 2024

Link: https://doi.org/10.3390/..

2

Combined Antitumor Effect of the Serine Protease Urokinase ..:

Asumda, Faizal Z. ; Campbell, Nellie A. ; Hassan, Mohamed A....
Cancers. 16 (2024) 5 - p. 1050 , 2024

Link: https://doi.org/10.3390/..

3

Author Correction: Partial inhibition of mitochondrial comp..:

Stojakovic, Andrea ; Trushin, Sergey ; Sheu, Anthony...
Communications Biology. 7 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

4

A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-..:

Kalogera, Eleftheria ; Nevala, Wendy K. ; Finnes, Heidi D....
Clinical Cancer Research. , 2024

Link: https://doi.org/10.1158/..

5

A phase 1 trial utilizing a pharmacokinetic endpoint to det..:

Pilbeam, Kristy L. ; Pradhan, Kamnesh ; Croop, James...
Pediatric Blood & Cancer. 71 (2024) 3 - p. , 2024

Link: https://doi.org/10.1002/..

6

Phase 1 trial of navitoclax and sorafenib in patients with ..:

Emiloju, Oluwadunni E. ; Yin, Jun ; Koubek, Emily...
Investigational New Drugs. 42 (2024) 1 - p. 127-135 , 2024

Link: https://doi.org/10.1007/..

7

Liposomal Phenylephrine Nanoparticles Enhance the Antitumor..:

Gabriel, Emmanuel M. ; Bahr, Deborah ; Rachamala, Hari Krishnareddy...
ACS Biomaterials Science & Engineering. 10 (2024) 5 - p. 3412-3424 , 2024

Link: https://doi.org/10.1021/..

8

A phase 1/2 study of pepinemab in children, adolescents, or..:

Greengard, Emily ; Williams, Robin ; Moriarity, Branden...
Pediatric Blood & Cancer. 71 (2024) 6 - p. , 2024

Link: https://doi.org/10.1002/..

9

Endoxifen downregulates AKT phosphorylation through protein..:

Jayaraman, Swaathi ; Wu, Xinyan ; Kalari, Krishna R....
npj Breast Cancer. 9 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

10

Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarco..:

Kim, Jin-Ah ; Crawford, Kenneth A. ; Spada, Piero A....
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

11

Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (A..:

Cole, Kristina A. ; Ijaz, Heba ; Surrey, Lea F....
Cancer. 129 (2023) 14 - p. 2245-2255 , 2023

Link: https://doi.org/10.1002/..

12

Development and validation of a liquid chromatography-mass ..:

Buhrow, Sarah A. ; Koubek, Emily J. ; Goetz, Matthew P...
Journal of Chromatography B. 1221 (2023) - p. 123654 , 2023

Link: https://doi.org/10.1016/..

13

Model‐informed approach to support pediatric dosing for the..:

Morcos, Peter N. ; Schlender, Jan ; Burghaus, Rolf...
Clinical and Translational Science. 16 (2023) 7 - p. 1197-1209 , 2023

Link: https://doi.org/10.1111/..

14

Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 a..:

Chi, Susan N ; Yi, Joanna S ; Williams, P Mickey...
JNCI: Journal of the National Cancer Institute. 115 (2023) 11 - p. 1355-1363 , 2023

Link: https://doi.org/10.1093/..

15

A phase 2 and pharmacological study of sapanisertib in pati..:

Al‐Kali, Aref ; Aldoss, Ibrahim ; Atherton, Pamela J....
Cancer Medicine. 12 (2023) 23 - p. 21229-21239 , 2023

Link: https://doi.org/10.1002/..